REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Inno Therapy Inc. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing | Scientific Research and Development Services
Full name: Inno Therapy Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The Company is a company mainly engaged in the research, development, manufacturing, export and sale of medical hemostatic agents. The main developed products include medical hemostats and sealants with biomimetic technology. The Company was established on April 19, 2010. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on February 01, 2019.

Headquarters
1210, 1206, 2Cha, Ace Hitech City, 25, Seonyu-Ro 13-Gil, Yeongdeungpo-Gu
Seoul; Seoul;

Contact Details: Purchase the Inno Therapy Inc. report to view the information.

Website: http://www.innotherapy.com

Basic Information
Total Employees:
Purchase the Inno Therapy Inc. report to view the information.
Outstanding Shares:
Purchase the Inno Therapy Inc. report to view the information.
Registered Capital:
Purchase the Inno Therapy Inc. report to view the information.
Financial Auditors:
Purchase the Inno Therapy Inc. report to view the information.
Incorporation Date:
April 19, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
25.1%
Purchase this report to view the information.
3.9%
Purchase this report to view the information.
0.6%
Subsidiaries
Innotherapy America Inc
Company Performance
Financial values in the chart are available after Inno Therapy Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
176.04%▲
Total operating revenue
35.72%▲
Operating profit (EBIT)
-63.35%▼
EBITDA
19.88%▲
Net Profit (Loss) for the Period
12.47%▲
Total assets
-15.79%▼
Total equity
38.63%▲
Operating Profit Margin (ROS)
647.55%▲
Net Profit Margin
1350.05%▲
Return on Equity (ROE)
18.73%▲
Debt to Equity Ratio
-61.94%▼
Quick Ratio
-1.76%▼
Cash Ratio
0.86%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo